OPZELURA 15 mg/g, crème — 1 tube(s) aluminium de 100 g

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400930270981
  • CIP7 3027098
  • CIS 68279528
  • Registration number EU/1/23/1726

What the source publishes

Holder
INCYTE BIOSCIENCES DISTRIBUTION (PAYS-BAS)
Active ingredients
PHOSPHATE DE RUXOLITINIB, RUXOLITINIB
Form
crème
Package
1 tube(s) aluminium de 100 g
Routes
cutanée
Administrative status
authorised
Supply regime
médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services MEDECINE INTERNE ; prescription réservée aux spécialistes et services DERMATOLOGIE ; liste I ; prescription réservée aux spécialistes et services ALLERGOLOGIE
Marketing status
Déclaration de commercialisation
Authorised on
2023-04-19
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400930270981
{
  "cis": "68279528",
  "cip7": "3027098",
  "form": "crème",
  "name": "OPZELURA 15 mg/g, crème — 1 tube(s) aluminium de 100 g",
  "cip13": "3400930270981",
  "holder": "INCYTE BIOSCIENCES DISTRIBUTION (PAYS-BAS)",
  "routes": [
    "cutanée"
  ],
  "holders": [
    "INCYTE BIOSCIENCES DISTRIBUTION (PAYS-BAS)"
  ],
  "currency": "EUR",
  "marketed": true,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": "839.41",
  "authorisedOn": "2023-04-19",
  "compositions": [
    {
      "name": "PHOSPHATE DE RUXOLITINIB",
      "nature": "SA",
      "strength": null,
      "linkageNumber": "1",
      "substanceCode": "38893",
      "dosageReference": null,
      "pharmaceuticalElement": "crème"
    },
    {
      "name": "RUXOLITINIB",
      "nature": "FT",
      "strength": "15 mg",
      "linkageNumber": "1",
      "substanceCode": "42140",
      "dosageReference": "1 g de crème",
      "pharmaceuticalElement": "crème"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services MEDECINE INTERNE ; prescription réservée aux spécialistes et services DERMATOLOGIE ; liste I ; prescription réservée aux spécialistes et services ALLERGOLOGIE",
  "dispensingFee": "1.02",
  "medicinePrice": "838.39",
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "OPZELURA 15 mg/g, crème",
  "marketingStatus": "Déclaration de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-11-20",
    "CIS_CIP_bdpm": "2026-11-20",
    "CIS_CPD_bdpm": "2026-11-20",
    "CIS_COMPO_bdpm": "2026-11-20"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "oui",
  "packageDescription": "1 tube(s) aluminium de 100 g",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [
    "65 %"
  ],
  "marketingDeclaredOn": "2024-01-31",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "PHOSPHATE DE RUXOLITINIB",
    "RUXOLITINIB"
  ],
  "authorisationProcedure": "Procédure centralisée",
  "prescriptionConditions": [
    "médicament nécessitant une surveillance particulière pendant le traitement",
    "prescription réservée aux spécialistes et services MEDECINE INTERNE",
    "prescription réservée aux spécialistes et services DERMATOLOGIE",
    "liste I",
    "prescription réservée aux spécialistes et services ALLERGOLOGIE"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": "EU/1/23/1726",
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400930270981"